tm logo
EPIMOGRIFY
Live/Registered
REGISTERED

on 06 Feb 2024

Last Applicant/ Owned by

Milton Road, Cambridge Cambridgeshire CB4 0FW

GB

Serial Number

79347429 filed on 22nd Mar 2022

Registration Number

7295995 registered on 06th Feb 2024

in the Principal Register

Correspondent Address

Rebecca Liebowitz

Rebecca Liebowitz Venable LLP

Washington, DC 20043-9998

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

EPIMOGRIFY

Scientific and technological services namely research and design analysis in the field of cell and gene therapies; industrial research services in the field of cell and gene therapies; medical and veterinary research services namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human an Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; cell and gene therapy services, namely, manipulation of human and animal cells for therapeutic purposes; medical services, namely, reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services namely research and design analysis in the field of cell and gene therapies; industrial research services in the field of cell and gene therapies; medical and veterinary research services namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy and gene therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; medical laboratory services; medical research laboratory services, in the field of cell and gene therapies; software as a service (SaaS) services featuring software for use in epigenomic data analysis; platform as a service (Paas) services featuring a bioinformatics software platform for use in manufacturing therapeutics; providing an online non-downloadable bioinformatics software platform for identifying transcription factors, ligands and cell surface receptors to turn one cell type into another cell type; providing an online non-downloadable bioinformatics platform for identifying transcription factors, ligands and cell surface receptors to maintain cell conversion; advisory and consultancy relating to all the aforesaid services


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [009]
Computer & Software Products & Electrical & Scientific Products


Downloadable bioinformatics software for epigenomic data analysis; downloadable computer software platforms for epigenomic data analysis in the field of cell and gene therapies; downloadable bioinformatics computer software platforms for epigenomic data analysis in the field of cell and gene therapies; scientific apparatus for measuring and analysing scientific study data, namely, apparatus for recording, transmission or reproduction of data, video, audio, images and text; data analysis apparatus,namely, data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Medical and veterinary preparations for therapeutic purposes, namely pharmaceutical, biopharmaceutical and veterinary preparations for use in maintaining cell identity and to support the reprogramming of cells in chemically defined media; pharmaceutical and biopharmaceutical preparations for cell and gene therapy; biological preparations for modifying human or animal cells for medical or therapeutic purposes, namely, transcription factors, ligands and cell surface receptors for use in maintaining cell identity and to support the reprogramming of cells in chemically defined media; biological, chemical and biochemical reagents for medical use; cells for medical or clinical use; vaccines


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Reagents for research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for scientific and research use; chemical substances, namely transcription factors and ligands for scientific and industrial use; cells for scientific and research use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Treatment and processing of biological materials, namely cells, stem cells, induced pluripotent stem cells; custom manufacture of therapeutic drugs; custom manufacture of transcription factors, ligands, cell surface receptors, cells, cell therapies and gene therapies; information, advisory and consultancy services in relation to all of the aforesaid services


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79347429

Mark Type

No Service Mark

Attorney Docket Number

No 60895-584341

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th Jun 2024FINAL DECISION TRANSACTION PROCESSED BY IB
09th May 2024FINAL DISPOSITION PROCESSED
09th May 2024FINAL DISPOSITION NOTICE SENT TO IB
06th May 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13th Feb 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
06th Feb 2024REGISTERED-PRINCIPAL REGISTER
24th Jan 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24th Jan 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21st Nov 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED